Article thumbnail

Validation of the 2009 TNM Classification for Renal Cell Carcinoma: Comparison with the 2002 TNM Classification by Concordance Index

By Chunwoo Lee, Dalsan You, Junsoo Park, In Gab Jeong, Cheryn Song, Jun Hyuk Hong, Hanjong Ahn and Choung-Soo Kim
Topics: Original Article
Publisher: The Korean Urological Association
OAI identifier: oai:pubmedcentral.nih.gov:3162217
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A postoperative prognostic nomogram for renal cell carcinoma.
  2. An outcome prediction model for patients with clear cell renal Korean J Urol 2011;52:524-530 530 Lee et al cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.
  3. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
  4. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
  5. Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma.
  6. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
  7. Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort.
  8. Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?
  9. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.
  10. Prognostic impact of the 2009 UICC/ AJCC TNM staging system for renal cell carcinoma with venous extension.
  11. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
  12. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters.
  13. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
  14. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?
  15. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome.
  16. pT2 classification for renal cell carcinoma. Can its accuracy be improved?
  17. Reassessing the current TNM lymph node staging for renal cell carcinoma.
  18. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.
  19. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy.
  20. Renal cell carcinoma guideline.
  21. Rising incidence of small renal masses: a need to reassess treatment effect.
  22. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?
  23. T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas.
  24. The process for continuous improvement of the TNM classification.
  25. (2002). TNM staging system in conventional and papillary localized renal cell carcinoma.
  26. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion.
  27. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?